---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-027846"
form_type: "8-K"
ticker: "MNPR"
cik: "0001645469"
company_name: "Monopar Therapeutics"
filed_at: "2024-08-27T23:59:59+00:00"
generated_at: "2026-05-31T07:24:34.369556+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Monopar regains compliance with Nasdaq minimum bid price rule

## Summary
- Received Nasdaq notice that closing bid price was $1.00+ for 10 consecutive trading sessions.
- Compliance regained under Nasdaq Listing Rule 5550(a)(2), avoiding delisting risk.
- Company remains listed on Nasdaq Capital Market under ticker MNPR.
- Press release dated August 27, 2024; no other material updates provided.

## SEC filing metadata
- accession: 0001437749-24-027846
- form_type: 8-K
- ticker: MNPR
- cik: 0001645469
- company_name: Monopar Therapeutics
- filed_at: 2024-08-27T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645469/000143774924027846/0001437749-24-027846-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645469/000143774924027846/mnpr20240827_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-027846
- JSON: https://secwatch.observer/filing/0001437749-24-027846.json
- Plain text: https://secwatch.observer/filing/0001437749-24-027846.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.